Signal52

FOLD

NEUTRALM&A

Amicus Therapeutics, Inc.

Price
$14.30
+0.14%
Score16.0Top Tier
Signals5/8 DNA3/13 Act · 1/4 Risk
SentimentNEUTRALScore: 8
Volume3.0xvs 20d avg

Analysis

FOLD is currently tethered to a 'Merger Arbitrage' dynamic following BioMarin's (BMRN) agreed all-cash acquisition offer of $14.50/share (Dec 2025). The 3.0x volume spike and 'Perfect Stack' signals are not a traditional breakout, but rather 'Institutional Absorption' as arbitrageurs digest the float following favorable long-term data presented at the WORLDSymposium (Feb 3-6) and BioMarin's successful $850M bond offering to fund the deal. In this 'Risk-On' regime, the market is aggressively pricing in deal completion, compressing the spread.

Fired Signals

ALPHA MALEQUIET STORMGOLDEN CROSSBOLLINGER SQUEEZEPERFECT STACKQUIET ACCUMULATIONSMA BOUNCESTOCHASTIC POPCHURNING
© 2026 Signal52 • For educational purposes only